XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-based Compensation (Tables)
 9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Based Compensation Cost We recorded stock-based compensation expense in the following categories in the accompanying unaudited condensed consolidated statements of operations and balance sheets (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
(Restated)(Restated)
Cost of revenue
$1,115 $597 $3,094 $2,205 
Sales and marketing
1,623 2,972 $4,602 $9,633 
Technology and development
4,706 3,857 $13,901 $12,303 
General and administrative
8,138 12,352 $29,408 $40,349 
Total stock-based compensation expense
15,582 19,778 $51,005 $64,490 
Amount capitalized to internal-use software
1,054 549 $3,039 $1,779 
Total stock-based compensation expense
$16,636 $20,327 $54,044 $66,269 
Schedule of Fair Value Assumptions and Techniques for Stock Options The weighted-average assumptions that were used to calculate the grant-date fair value of our stock option grants using the Black-Scholes option pricing model were as follows:
Nine Months Ended September 30,
2023
Expected life (years)
5.87
Risk-free interest rate
3.4% - 3.8%
Expected volatility
50.4% - 50.7%
Expected dividend yield
—